4.2 Review

MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness

期刊

MAMMALIAN GENOME
卷 20, 期 9-10, 页码 581-603

出版社

SPRINGER
DOI: 10.1007/s00335-009-9230-5

关键词

-

资金

  1. NIH [R01 DC005641]
  2. Israel Science Foundation [1486/07]
  3. European Commission FP6 Integrated Projects EuroHear [LSHG-CT-20054-512063, Eumodic 037188]
  4. NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Sensorineural hearing loss is the most common sensory disorder in humans and derives, in most cases, from inner-ear defects or degeneration of the cochlear sensory neuroepithelial hair cells. Genetic factors make a significant contribution to hearing impairment. While mutations in 51 genes have been associated with hereditary sensorineural nonsyndromic hearing loss (NSHL) in humans, the responsible mutations in many other chromosomal loci linked with NSHL have not been identified yet. Recently, mutations in a noncoding microRNA (miRNA) gene, MIR96, which is expressed specifically in the inner-ear hair cells, were linked with progressive hearing loss in humans and mice. Furthermore, additional miRNAs were found to have essential roles in the development and survival of inner-ear hair cells. Epigenetic mechanisms, in particular, DNA methylation and histone modifications, have also been implicated in human deafness, suggesting that several layers of noncoding genes that have never been studied systematically in the inner-ear sensory epithelia are required for normal hearing. This review aims to summarize the current knowledge about the roles of miRNAs and epigenetic regulatory mechanisms in the development, survival, and function of the inner ear, specifically in the sensory epithelia, tectorial membrane, and innervation, and their contribution to hearing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

miR-96 is required for normal development of the auditory hindbrain

Tina Schlueter, Christina Berger, Elena Rosengauer, Pascal Fieth, Constanze Krohs, Kathy Ushakov, Karen P. Steel, Karen B. Avraham, Alexander K. Hartmann, Felix Felmy, Hans Gerd Nothwang

HUMAN MOLECULAR GENETICS (2018)

Review Neurosciences

Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges

Shahar Taiber, Karen B. Avraham

NEUROSCIENCE LETTERS (2019)

Article Behavioral Sciences

A mouse model for benign paroxysmal positional vertigo with genetic predisposition for displaced otoconia

Amiel A. Dror, Shahar Taiber, Eyal Sela, Ophir Handzel, Karen B. Avraham

GENES BRAIN AND BEHAVIOR (2020)

Article Biochemistry & Molecular Biology

Homozygote loss-of-function variants in the humanCOCHgene underlie hearing loss

Nada Danial-Farran, Elena Chervinsky, Prathamesh T. Nadar-Ponniah, Eran Cohen Barak, Shahar Taiber, Morad Khayat, Karen B. Avraham, Stavit A. Shalev

Summary: A new variant of the COCH gene was found to have a loss-of-function effect, resulting in a significant decrease in cochlin translation, which has a dramatic impact on the accuracy of genetic counseling for carriers of LOF variants in COCH.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Multidisciplinary Sciences

Mechanical forces drive ordered patterning of hair cells in the mammalian inner ear

Roie Cohen, Liat Amir-Zilberstein, Micha Hersch, Shiran Woland, Olga Loza, Shahar Taiber, Fumio Matsuzaki, Sven Bergmann, Karen B. Avraham, David Sprinzak

NATURE COMMUNICATIONS (2020)

Article Medicine, Research & Experimental

Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness

Shahar Taiber, Roie Cohen, Ofer Yizhar-Barnea, David Sprinzak, Jeffrey R. Holt, Karen B. Avraham

Summary: Genetic variants play a significant role in congenital and early-onset deafness, with SYNE4 mutations leading to DFNB76 human deafness. Using AAV9-PHP.B for gene therapy in mice showed promising results in rescuing hair cell morphology and survival, restoring auditory function, and associated behaviors. Further research is needed to determine the long-term effectiveness and optimal intervention timing in humans.

EMBO MOLECULAR MEDICINE (2021)

Article Genetics & Heredity

PNPT1, MYO15A, PTPRQ, and SLC12A2-associated genetic and phenotypic heterogeneity among hearing impaired assortative mating families in Southern India

Paridhy S. Vanniya, Jayasankaran Chandru, Justin Margret Jeffrey, Tom Rabinowitz, Zippora Brownstein, Mathuravalli Krishnamoorthy, Karen B. Avraham, Le Cheng, Noam Shomron, C. R. Srikumari Srisailapathy

Summary: This study identified novel variants in PNPT1, PTPRQ, and SLC12A2 genes that are associated with hearing loss in the Indian population, highlighting the high level of genetic and phenotypic heterogeneity of hearing loss in these families.

ANNALS OF HUMAN GENETICS (2022)

Review Genetics & Heredity

The noncoding genome and hearing loss

Karen B. Avraham, Lama Khalaily, Yael Noy, Lara Kamal, Tal Koffler-Brill, Shahar Taiber

Summary: The sequencing era has provided unprecedented insights into the human genome, revealing nearly 20,000 genes in the coding region, including around 4,000 associated with human diseases; a vast pool of regulatory elements beyond the protein-coding genome influences human health and disease; ongoing research on microRNAs, long non-coding RNAs, methylation, and histone modifications suggests promise for future therapeutic and diagnostic tools.

HUMAN GENETICS (2022)

Editorial Material Multidisciplinary Sciences

Emerging complexities of the mouse as a model for human hearing loss

Ryan J. Carlson, Karen B. Avraham

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Audiology & Speech-Language Pathology

The long and short: Non-coding RNAs in the mammalian inner ear

Tal Koffler-Brill, Yael Noy, Karen B. Avraham

Summary: Non-coding RNAs (ncRNAs) are crucial for the body's functioning, and their dysregulation is often linked to diseases. This review provides an overview of the different classes of ncRNAs and their roles in physiological and pathological conditions, with a focus on their significance in the inner ear, hearing, and deafness.

HEARING RESEARCH (2023)

Article Immunology

Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity

Rei Matsumoto, Joshua Gray, Ksenia Rybkina, Hanna Oppenheimer, Lior Levy, Lilach M. Friedman, Muhammad Khamaisi, Wenzhao Meng, Aaron M. Rosenfeld, Rebecca S. Guyer, Marissa C. Bradley, David Chen, Mark A. Atkinson, Todd M. Brusko, Maigan Brusko, Thomas J. Connors, Eline T. Luning T. Prak, Uri Hershberg, Peter A. Sims, Tomer Hertz, Donna L. Farber

NATURE IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Shared and organ-specific gene-expression programs during the development of the cochlea and the superior olivary complex

Mor Bordeynik-Cohen, Michal Sperber, Lena Ebbers, Naama Messika-Gold, Constanze Krohs, Tal Koffler-Brill, Yael Noy, Ran Elkon, Hans Gerd Nothwang, Karen B. Avraham

Summary: This study explores the interactions and common expression pathways of the central and peripheral auditory systems during development using genomics approaches. It identifies miRNAs as critical factors for proper auditory system development.

RNA BIOLOGY (2023)

Article Multidisciplinary Sciences

Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2

Tomer Hertz, Shlomia Levy, Daniel Ostrovsky, Hanna Oppenheimer, Shosh Zismanov, Alona Kuzmina, Lilach M. Friedman, Sanja Trifkovic, David Brice, Lin Chun-Yang, Liel Cohen-Lavi, Yonat Shemer-Avni, Merav Cohen-Lahav, Doron Amichay, Ayelet Keren-Naus, Olga Voloshin, Gabriel Weber, Ronza Najjar-Debbiny, Bibiana Chazan, Maureen A. McGargill, Richard Webby, Michal Chowers, Lena Novack, Victor Novack, Ran Taube, Lior Nesher, Orly Weinstein

Summary: Vaccination provides population-level protection against COVID-19, but emerging variants and waning immunity pose risks at the individual level. A study found that a fourth dose of the Pfizer-BNT162b2 vaccine significantly increased antibody titers against variants of concern, reducing the risk of symptomatic infection by 37%. However, individuals with low baseline antibody levels remained susceptible to infection despite boosting.

NATURE COMMUNICATIONS (2023)

Article Biotechnology & Applied Microbiology

Reduced changes in protein compared to mRNA levels across non-proliferating tissues

Kobi Perl, Kathy Ushakov, Yair Pozniak, Ofer Yizhar-Barnea, Yoni Bhonker, Shaked Shivatzki, Tamar Geiger, Karen B. Avraham, Ron Shamir

BMC GENOMICS (2017)

暂无数据